Marimed Inc. (MRMD): who owns it and who trades it
As of Oct 30, 2026, MRMD insiders reported 5 purchases worth $12.8K in the last 12 months. The largest buyer was Jon R Levine (CEO), with $7.8K.
Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, MRMD insiders reported $12.8K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | Jon R Levine | CEO | Purchase | 37,000 | $0.08 | $3K | Form 4 |
| May 22, 2026 | Jon R Levine | CEO | Purchase | 3,000 | $0.08 | $240 | Form 4 |
| May 22, 2026 | Jon R Levine | CEO | Purchase | 20,000 | $0.07 | $1.4K | Form 4 |
| May 20, 2026 | Jon R Levine | CEO | Purchase | 40,000 | $0.08 | $3.2K | Form 4 |
| Dec 12, 2025 | Timothy Shaw | Chief Operating Officer | Purchase | 45,455 | $0.11 | $5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jon R Levine | President and CEO, Director, 10% owner | $7.8K | – | May 22, 2026 |
| Timothy Shaw | Chief Operating Officer | $5K | – | Dec 12, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MRMD short interest
Low short interest. Less than 0.1% of MRMD shares are sold short. Over the last 12 reports the number of shares short went up 456%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 18,486 MRMD shares were sold short, 0.0% of the shares outstanding, up 1748.6% from the report before. At the average daily volume of 761,607 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 18,486 | 0.00% | +1749% | 761,607 | 1.0 |
| Oct 15, 2026 | 1,000 | 0.00% | No change | 999,138 | 1.0 |
| Sep 30, 2026 | 1,000 | 0.00% | -98% | 1.66M | 1.0 |
| Sep 15, 2026 | 44,669 | 0.01% | +113% | 769,089 | 1.0 |
| Aug 31, 2026 | 20,999 | 0.01% | -4% | 1.83M | 1.0 |
| Aug 14, 2026 | 21,955 | 0.01% | +124% | 473,231 | 1.0 |
| Jul 31, 2026 | 9,792 | 0.00% | +152% | 433,915 | 1.0 |
| Jul 15, 2026 | 3,893 | 0.00% | +109% | 548,629 | 1.0 |
| Jun 30, 2026 | 1,866 | 0.00% | -88% | 668,174 | 1.0 |
| Jun 15, 2026 | 16,030 | 0.00% | -75% | 1.41M | 1.0 |
| May 29, 2026 | 64,138 | 0.02% | +1828% | 1.25M | 1.0 |
| May 15, 2026 | 3,327 | 0.00% | -84% | 1.29M | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Marimed company events
Marimed filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 29, 2026.
- Oct 29, 2026AnnouncementThe Company issued a press release announcing the voting results for the Special Meeting. Filing
- Sep 23, 2026AnnouncementMariMed Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing the filing of a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with a special meeting of stockholders to seek… Filing
- Aug 12, 2026ResultsReleased financial results. Filing
- Jun 8, 2026VoteReported shareholder vote results. Filing
- May 13, 2026ResultsReleased financial results. Filing
- Mar 11, 2026ResultsReleased financial results. Filing
- Mar 2, 2026AgreementBackground In November 2018, Navy Capital Green International, Ltd. and its affiliates (collectively, “Navy”) purchased 4,908,333 shares of MariMed Inc. common stock in a private placement financing for $3.00 per share, or aggregate consideration of $14.72 million. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Marimed financials
Questions about Marimed Inc. (MRMD) stock
Are MRMD insiders buying or selling?
In the last 12 months, MRMD insiders reported 5 open-market purchases worth $12.8K and no sales. The latest trade was on May 22, 2026. See every trade.
What is the short interest in MRMD?
As of Oct 30, 2026, 18,486 MRMD shares were sold short, 0.0% of the shares outstanding, up 1748.6% from the report before. At the average daily volume of 761,607 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.